Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott D Cramer

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Developmental Cell|May 25, 2016
The Autophagy Machinery Controls Cell Death Switching between Apoptosis and NecroptosisMegan L Goodall, Brent E Fitzwalter, Shadi Zahedi, et al.
Molecular Cancer Research : MCR|July 14, 2019
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous RecombinationSatoshi Washino, Leah C Rider, Lina Romero, et al.
Cancer Research|September 3, 2004
The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme functionKristin L Lockett, M Craig Hall, Jianfeng Xu, et al.
Molecular Therapy Oncolytics|June 13, 2020
<i>MAP3K7</i> and <i>CHD1</i> Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer CellsRobert S Bayne, Shelby Puckett, Lindsey Ulkus Rodrigues, et al.
Carcinogenesis|January 27, 2004
Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3Gary G Schwartz, Dawn Eads, Anuradha Rao, et al.
Molecular Cancer Therapeutics|August 15, 2014
Lipid catabolism via CPT1 as a therapeutic target for prostate cancerIsabel R Schlaepfer, Leah Rider, Lindsey Ulkus Rodrigues, et al.
The Prostate|October 19, 2002
Sequence variants in the human 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer riskGregory A Hawkins, Scott D Cramer, Siqun L Zheng, et al.
Molecular Imaging and Biology|January 7, 2015
Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse XenograftsIsabel R Schlaepfer, L Michael Glodé, Carolyn A Hitz, et al.
Molecular Cancer Research : MCR|August 5, 2018
CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD<sup>+</sup> PoolsJeffrey P Chmielewski, Sarah C Bowlby, Frances B Wheeler, et al.
The Prostate|January 1, 2009
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancerFredrik Wiklund, S Lilly Zheng, Jielin Sun, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Developmental Cell|May 25, 2016
The Autophagy Machinery Controls Cell Death Switching between Apoptosis and NecroptosisMegan L Goodall, Brent E Fitzwalter, Shadi Zahedi, et al.
Molecular Cancer Research : MCR|July 14, 2019
Loss of MAP3K7 Sensitizes Prostate Cancer Cells to CDK1/2 Inhibition and DNA Damage by Disrupting Homologous RecombinationSatoshi Washino, Leah C Rider, Lina Romero, et al.
Cancer Research|September 3, 2004
The ADPRT V762A genetic variant contributes to prostate cancer susceptibility and deficient enzyme functionKristin L Lockett, M Craig Hall, Jianfeng Xu, et al.
Molecular Therapy Oncolytics|June 13, 2020
<i>MAP3K7</i> and <i>CHD1</i> Are Novel Mediators of Resistance to Oncolytic Vesicular Stomatitis Virus in Prostate Cancer CellsRobert S Bayne, Shelby Puckett, Lindsey Ulkus Rodrigues, et al.
Carcinogenesis|January 27, 2004
Pancreatic cancer cells express 25-hydroxyvitamin D-1 alpha-hydroxylase and their proliferation is inhibited by the prohormone 25-hydroxyvitamin D3Gary G Schwartz, Dawn Eads, Anuradha Rao, et al.
Molecular Cancer Therapeutics|August 15, 2014
Lipid catabolism via CPT1 as a therapeutic target for prostate cancerIsabel R Schlaepfer, Leah Rider, Lindsey Ulkus Rodrigues, et al.
The Prostate|October 19, 2002
Sequence variants in the human 25-hydroxyvitamin D3 1-alpha-hydroxylase (CYP27B1) gene are not associated with prostate cancer riskGregory A Hawkins, Scott D Cramer, Siqun L Zheng, et al.
Molecular Imaging and Biology|January 7, 2015
Inhibition of Lipid Oxidation Increases Glucose Metabolism and Enhances 2-Deoxy-2-[(18)F]Fluoro-D-Glucose Uptake in Prostate Cancer Mouse XenograftsIsabel R Schlaepfer, L Michael Glodé, Carolyn A Hitz, et al.
Molecular Cancer Research : MCR|August 5, 2018
CD38 Inhibits Prostate Cancer Metabolism and Proliferation by Reducing Cellular NAD<sup>+</sup> PoolsJeffrey P Chmielewski, Sarah C Bowlby, Frances B Wheeler, et al.
The Prostate|January 1, 2009
Association of reported prostate cancer risk alleles with PSA levels among men without a diagnosis of prostate cancerFredrik Wiklund, S Lilly Zheng, Jielin Sun, et al.
Pageof 6